Baccuico has developed a proprietary bacterial cultivation platform that combines directed evolution, next generation sequencing, and machine learning to access novel compounds from biological ‘dark matter’. The company’s Bacterial Community Cultivation platform (BACCU) directs the evolution of unculturable bacteria, so that the bacteria evolve to become culturable in the lab. Once brought into the laboratory, […]

View post to subscribe to site newsletter.

ExploRNA Therapeutics is a spin-off from the University of Warsaw, developing next generation mRNA technology for applications such as anti-cancer vaccines. ExploRNA Therapeutics was founded by Professor Jacek Jemielity, Head of the Bio Organic Chemistry Laboratory at the Center of New Technologies CeNT at the University of Warsaw. Professor Jemielity’s first generation ‘cap modification’ mRNA […]

View post to subscribe to site newsletter.

Acrigen Biosciences is developing technologies to improve the efficiency and enhance the safety of CRISPR-Cas based gene editing, with the aim of eliminating the threat of unintended editing causing severe complications and side effects. The company’s technology is based on a class of proteins, anti-CRISPR or Acr proteins, that precisely deactivate the Cas proteins serving […]

View post to subscribe to site newsletter.